Drugmakers Increase Capital Investment

Drugmakers operating in Germany increased their investment in plants and equipment in 2006, according to a recent survey by the research-based drug industry organisation, VFA, although the market is failing to attract new investors. The VFA claims that its members spent EUR1.5bn (US$2.03bn) upgrading facilities last year, an increase of around 20%, with the highest spend coming from Swiss drugmaker

To read the full article, please sign in or take a free trial.